|Home | About | Journals | Submit | Contact Us | Français|
Clean intermittent catheterization (CIC) is an important asset in managing children with noncompliant bladders. We review the feasibility and late outcomes of patients with normal urethral sensation who began CIC.
We reviewed all patients with posterior urethral valve (PUV) or non-neuropathic bladder sphincter dysfunction (NNBSD) who began on CIC, and had at least 2 years of follow-up. We considered their age, indication, acceptance and compliance with CIC. Additionally, we examined the late outcome of bladder function and the need for any surgical intervention at follow-up.
Between 1999 and 2006, 52 patients with PUV (38 patients) or NNBSD (14 patients) were started on CIC. Of these 52 patients, 48% were under the age of 4. A total of 44 patients (85%) accepted the recommendation for CIC, and 34 patients (65%) were compliant with the protocol after at least 2 years of follow-up. The age of the patients was the only significant factor related to the success of the protocol (4 years old or younger, p = 0.03). After at least 2 years of follow-up, 28 patients (54%) remained on CIC and have not required urinary diversion or bladder reconstruction.
The current study showed that CIC is a feasible option for patients with sensate urethra, which necessitates the introduction of treatment as early as possible. Further, those patients who are compliant with the CIC demonstrated a better chance of avoiding subsequent surgical intervention for the management of a non-compliant bladder.
Le cathétérisme intermittent propre (CIP) est un élément important de la prise en charge de l’insuffisance vésicale chez les enfants. Nous passons ici en revue la faisabilité et les résultats tardifs chez des patients affichant des sensations urétrales normales qui ont entrepris un traitement par CIP.
Nous avons examiné tous les patients atteints d’une dysfonction de la valve urétrale postérieure (DVUP) ou d’une dysfonction non névrotique du sphincter vésical (DNNSV) ayant entrepris un traitement par CIP, et suivis pendant au moins 2 ans. Nous avons tenu compte de leur âge, de l’indication du traitement, de leur acceptation et leur observance du traitement par CIP. En outre, nous avons examiné les résultats tardifs de la fonction vésicale et le besoin de recourir à tout type d’intervention chirurgicale lors du suivi.
Entre 1999 et 2006, 52 patients atteints de DVUP (38 patients) ou de DNNSV (14 patients) ont entrepris un traitement par CIP. De ce nombre, 48 % avaient moins de 4 ans. Au total, 44 patients (85 %) ont accepté la recommandation de procéder au CIP, et 34 patients (65 %) observaient toujours le traitement après au moins 2 ans de suivi. L’âge des patients représentait le seul facteur significatif lié à la réussite du traitement (4 ans ou moins, p = 0,03). Après au moins 2 ans de suivi, 28 patients (54 %) poursuivaient leur traitement par CIP et n’avaient pas besoin d’un détournement urinaire ou d’une reconstruction de la vessie.
Notre étude a montré que le CIP est une option raisonnable pour les patients avec urètre sensible, qui nécessite l’instauration d’un traitement le plus rapidement possible. Par ailleurs, les patients qui observent bien le traitement par CIP présentaient de meilleures chances d’éviter une intervention chirurgicale subséquente pour le traitement d’une insuffisance vésicale.
Children with both non-neuropathic at-risk bladder secondary to posterior urethral valve (PUV) and non-neuropathic bladder sphincter dysfunction (NNBSD) are a challenge to manage. The children and their families fail to appreciate the complexity of the problem, as the child looks normal and voids normally. Patients and their families may not understand that poor compliance with the treatment protocol could lead to end-stage renal failure in some patients.
The main goal in managing at an at-risk bladder is to lower the intravesical pressure to a safe limit, usually by combining anticholinergic medications and clean intermittent catheterization (CIC).1 If this line of treatment is unfeasible or the bladder is refractory to this conservative management, patients may need either non-continent diversion or bladder reconstruction with a continent bladder stoma to preserve their renal function.2 As expected, CIC per sensate urethra is a challenge to master, as the compliance of the child and caregiver is difficult to attain.3–5
This report assesses the feasibility of CIC in patients with sensate urethra. The paper also examines the fate of the bladder in the long follow-up period.
A retrospective review of the files of patients diagnosed with PUV or NNBSD in the local unit between 1999 and 2007 was performed. Patients who needed to start CIC per sensate urethra for their at-risk poorly compliant bladder were included. The following factors were examined: acceptance and compliance with CIC, late outcome fate of the bladder, whether this line of treatment was sufficient to protect the upper tract, and the necessity for further surgical interventions.
Clean intermittent catheterization training was done by the urotherapist in the outpatient clinic. Patients with PUV were kept with overnight drainage if hydronephrosis persisted.
Acceptance was defined as the time when the child and caregiver were ready to start CIC after their first visit with the urotherapist. Compliance was evaluated as whether the caregiver/child was compliant with the protocol for at least 2 years after starting the program. At that time, the child will either: 1) be compliant with CIC, 2) have undergone a urinary diversion, 3) have had bladder reconstruction, or 4) have not had any active treatment but are still being followed-up.
A total of 38 patients with PUV and 14 patients with NNBSB began CIC per sensate urethra in the urotherapy laboratory since 1999 (Table 1). Clean intermittent catheterization was initiated because of a noncompliant at-risk bladder with or without urinary incontinence in 49 patients; an additional 3 patients started CIC due to high postvoid residue.
Of the 52 patients, 44 (85%) demonstrated acceptance of the procedure and attended training (Fig. 1). Among the 44 children who accepted and mastered CIC, 77% (34 patients, representing 65% of the entire group) were still compliant after at least 2 years of follow-up.
A total of 25 patients (48%) were 4 years old or younger, and 27 (52%) were over 4 years old upon initiation of the CIC protocol. For those 4 years or younger, 80% were compliant with CIC after at least 2 years of follow-up, and only 52% of those over 4 years old were compliant at this time (p = 0.03) (Table 1) (Fig. 2). Children who needed CIC per sensate urethra had a 54% (28/52) chance of stabilizing their upper tract, mastering the protocol, achieving compliance and avoiding surgical intervention.
The management of children with neuropathic or non-neuropathic bladder dysfunction is a challenge that requires a team approach. When the condition is severe enough that a patient must started CIC, resistance from the child and the family is understandable; this is particularly true when the child possesses normal urethral sensation. Of the 52 patients in our unit with sensate urethra who required CIC, 34 (65%) where able to begin and continue the program. This finding is consistent with values from previously published reports;3–5 however, this number is less than the number observed in our experience with patients with myelominigocele (MMC).6 This discrepancy can be explained by the lack of urethral sensation in MMC patients.
The key factor for success in such a treatment modality is a dedicated team with sufficient time to explain the need for a CIC program, how the program will be conducted, and the negative consequences on the bladder and kidneys if CIC is not performed properly. Another important factor associated with success is a discussion with the families and their children; this should preferably take place before CIC starts. We found that this group discussion encourages compliance and alleviates a significant amount of fear in newly-treated families on the CIC program.
The only significant parameter observed for a successful program was the age at which CIC was initiated; age was significantly different (p = 0.03) for children beginning CIC per sensate urethra at or before the age of 4, compared with those for whom CIC was started after the age of 4. Other parameters, such as the presence of vesicoureteric reflux or hydronephrosis, had no significant effect on the success of the protocol.
Among the 52 patients, 34 (65%) were still compliant with CIC after at least 2 years of follow-up (Fig. 1), and a total of 28 patients (54%) are still on the CIC program with a stable bladder; none of these patients required incontinent diversion or bladder reconstruction (Fig. 2). Comparing both age groups, only 18% of those under the age of 4 needed surgical intervention, whereas 72% of the older children needed surgical intervention.
The group of patients described in this paper is difficult to manage. The described treatment modality is a challenge (because of the difficulty in convincing the children and their parents in the initial phase), however with proper compliance, it is worth trying. A positive outcome of the CIC method is the reduced need for surgical intervention later on.
As the current study is a retrospective study, the need for a larger prospective evaluation with a longer follow-up period with a control group is needed to further evaluate the final outcome of the CIC program per sensate urethra.
The current study shows that CIC is a feasible option in the management of patients with sensate urethra who need to begin treatment as early as possible. Furthermore, patients who are compliant with CIC have a better chance of avoiding subsequent surgical intervention for the management of bladder non-compliance.
Competing interests: None declared.
This paper has been peer-reviewed.